Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or ...

In Phase I studies, BI 765423 showed a favorable safety and tolerability profile in healthy volunteers across a wide dose range. The Phase IIa study will be the first to evaluate its efficacy in ...

When asked about the cost of the USC’s partnership with OpenAI, interim Chief Information Officer Midhat Asghar wrote to the ...

Lexus has long become a byword for performance and comfort, but these models prove that Toyota's luxury marque is capable of ...

Fakeeh Health | CEO – Fakeeh University Hospital, stated: “This strategic partnership with Verita Neuro reflects our ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Korean Air reopens its Prestige East Lounge at Incheon, expanding premium capacity and introducing digital tools ahead of its ...

Advancing icovamenib toward late-stage clinical development in two Phase II clinical trials in patients with insulin-deficient type 2 diabetes (“T2D”) and in T2D patients currently failing ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

The air at the temple’s gopura vaasal is not merely still; it is thick and long before the visual spectacle of the deity ...

Moving Biotech receives US FDA’s IND clearance for 4P004; strengthens its position as a leading innovator in disease-modifying osteoarthritis therapeutics: Lille, France Saturd ...

RSSB declared the Group D Merit List & Cut Off PDF at rssb.rajasthan.gov.in. Check your result & download scorecard here from ...